Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Munster, IN
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Munster, IN
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Baton Rouge, LA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Lake Charles, LA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
New Orleans, LA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Columbia, MD
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Columbia, MD
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Flowood, MS
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
St. Louis, MO
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
North Platte, NE
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
North Platte, NE
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Albuquerque, NM
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Buffalo, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Cedarhurst, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Elmsford, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Elmsford, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Holliswood, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Holliswood, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Jamaica, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Staten Island, NY
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Cleveland, OH
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Oklahoma City, OK
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Philadelphia, PA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Memphis, TN
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Austin, TX
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
DeSoto, TX
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
DeSoto, TX
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Bellevue, WA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Bothell, WA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Bothell, WA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Richland, WA
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Richland, WA
Click here to add this to my saved trials
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  6/16/2013
Otsuka Investigational Site
mi
from
Ciudad Autónoma de Bs. As.,
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 6/16/2013
Otsuka Investigational Site
mi
from
Ciudad Autónoma de Bs. As.,
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Woodland Research Northwest
mi
from
Springdale, AZ
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Woodland Research Northwest
mi
from
Springdale, AZ
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
K & S Professional Research Services
mi
from
Little Rock, AR
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
K & S Professional Research Services
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Woodland International Research Inc
mi
from
Little Rock, AR
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Woodland International Research Inc
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Diligent Clinical Trials
mi
from
Downey, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Diligent Clinical Trials
mi
from
Downey, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Synergy Clinical Research Center
mi
from
National City, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Synergy Clinical Research Center
mi
from
National City, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
CNS Network
mi
from
Torrance, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
CNS Network
mi
from
Torrance, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Excell Research, Inc.
mi
from
Oceanside, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
California Neuropsychopharmacolgoy Clinical Research Insitute
mi
from
San Diego, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
California Neuropsychopharmacolgoy Clinical Research Insitute
mi
from
San Diego, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Accurate Clinical Trials
mi
from
Kissimmee, FL
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Accurate Clinical Trials
mi
from
Kissimmee, FL
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Galiz Research
mi
from
Miami Springs, FL
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Galiz Research
mi
from
Miami Springs, FL
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Lousiana Clinical Research, LLC
mi
from
Shreveport, LA
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Lousiana Clinical Research, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Center for Behavioral Health, LLC
mi
from
Rockville, MD
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Center for Behavioral Health, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Psychiatric Care and Research Center
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Psych Care Consultants Research
mi
from
St. Louis, MO
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Psych Care Consultants Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated:  7/5/2013
Robert Lynn Horne, MD, Ltd.
mi
from
Las Vegas, NV
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
A Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
Status: Enrolling
Updated: 7/5/2013
Robert Lynn Horne, MD, Ltd.
mi
from
Las Vegas, NV
Click here to add this to my saved trials